U.S., Aug. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07121387) titled 'A Retrospective Cohort Analysis of SMARCA4-Deficient Lung Cancer' on Aug. 06.
Brief Summary: This is a single-center retrospective analysis to explore the clinical characteristics, therapeutic efficacy, and tumor immune microenvironment of SMARCA4-deficient advanced non-small-cell lung cancer (NSCLC).
Study Start Date: Jan. 01, 2020
Study Type: OBSERVATIONAL
Condition:
SMARCA4-Deficient Tumor
NSCLC (Advanced Non-small Cell Lung Cancer)
Recruitment Status: COMPLETED
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China
Information provided by (Responsible Party): Yayi He, Shanghai Pulmonary Hospital, Shanghai, China
Published...